RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Clopidogrel, Warfarin, and Statins: Pharmacogenetics versus Laboratory Monitoring - What You Need to Know
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 8
OP 9
DO 10.1177/155989771010002
UL http://mdc.sagepub.com/content/10/10/8.abstract
AB This article discusses the use of routine genetic and platelet function testing in the setting of clopidogrel treatment, the use of pharmacogenetics to determine warfarin dosing, predictive genetic testing for statin efficacy and toxicity, cost-effectiveness, and the United States Federal Drug Administration's role in pharmacogenetic data.